Предиктори відновлення синусового ритму в пацієнтів з тривалими епізодами персистентної фібриляції передсердь

Я.В. Скибчик, К.О. Міхалєв, О.Й. Жарінов

Література

1. Фібриляція і тріпотіння передсердь / За ред. О.Й. Жа­­­рінова, В.О. Куця. Київ: Четверта хвиля, 2022. 248 с.
2. Akamatsu K, Ito T, Ozeki M, Miyamura M, Sohmiya K, Hoshiga M. Left atrial spontaneous echo contrast occurring in patients with low CHADS2 or CHA2DS2-VASc scores. Cardiovasc Ultrasound. 2020;18(1):31. doi:10.1186/s12947-020-00213-2.
3. Benussi S, de Maat GE. Atrial remodelling and function: implications for atrial fibrillation surgery. Eur J Cardiothorac Surg. 2018;53(suppl_1):i2–i8. doi:10.1093/ejcts/ezx340.
4. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance. J Am Coll Cardiol. 1985;6(4):744–9. doi:10.1016/s0735-1097(85)80476-9.
5. Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol. 1991;18(2):398–404. doi:10.1016/0735-1097(91)90592-w.
6. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen  PS, Chen SA, Chung MK, Cosedis Nielsen J, Curtis  AB, Davies DW, Day JD, d’Avila A, Natasja de Groot NMS, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai  K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca  M, Schilling R, Tondo C, Tsao  HM, Verma A, Wilber DJ, Yamane T; Document Reviewers. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20(1):e1–e160. doi:10.1093/europace/eux274.
7. Daniel WG, Nellessen U, Schröder E, Nonnast-Daniel B, Bednarski P, Nikutta P, Lichtlen PR. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol. 1988;11(6):1204–11. doi:10.1016/0735-1097(88)90283-5. 
8. de Vos CB, Crijns HJ, Tieleman RG. The fibrillating atrial myocardium visualized: an unexploited source of information. Heart Rhythm. 2009;6(8):1247–8. doi:10.1016/j.hrthm.2008.11.003. 
9. Donghua Z, Jian P, Zhongbo X, Feifei Z, Xinhui P, Hao Y, Fuqiang L, Yan L, Yong X, Xinfu H, Surong M, Muli W, Dingli X. Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia. J Interv Card Electrophysiol. 2013;36(1):27–32; discussion 32. doi:10.1007/s10840-012-9727-9.
10. Dudink EAMP, Erküner Ö, Berg J, Nieuwlaat R, de Vos CB, Weijs B, Capucci A, Camm AJ, Breithardt G, Le Heuzey JY, Luermans JGLM, Crijns HJGM. The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey. Europace. 2018;20(6):929–34. doi:10.1093/europace/eux217.
11. Furniss SS, Sneyd JR. Safe sedation in modern cardiological practice. Heart. 2015;101(19):1526–30. doi:10.1136/heartjnl-2015-307656. 
12. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen  SA, Chugh SS, Corradi D, D’Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner  DR, Nattel  S; Document Reviewers: EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace. 2016;18(10):1455–90. doi:10.1093/europace/euw161.
13. Grebmer C, Lennerz C, Brkic A, Blazek P, Weigand S, Semmler  V, Kottmaier M, Bourier F, Friedrich L, Risse E, Brooks S, Kornmayer M, Telishevska M, Reents T, Kolb  C, Hessling G, Deisenhofer I. Prevalence and clinical correlates of spontaneous echo contrast in patients on oral anticoagulation undergoing catheter ablation for atrial fibrillation. Int J Clin Cardiol. 2019;6:151. doi.org/10.23937/2378-2951/1410151.
14. Gumprecht J, Szulik M, Domek M, Mazurek M, Shantsila  A, Oxborough D, Lip GYH. Novel echocardiographic biomarkers in the management of atrial fibrillation. Curr Cardiovasc Imaging Rep. 2019;12:43. doi:10.1007/s12410-019-9520-6.
15. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blom­­ström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane  DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas  GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612.
16. Inácio JF, da Rosa Mdos S, Shah J, Rosário J, Vissoci JR, Manica  AL, Rodrigues CG. Monophasic and biphasic shock for transthoracic conversion of atrial fibrillation: Systematic review and network meta-analysis. Resuscitation. 2016;100:66–75. doi: 10.1016/j.resuscitation.2015.12.009.
17. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8. doi:10.1038/bmt.2012.244.
18. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan  A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck  KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas  P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G; EAST-AFNET 4 Trial Investigators. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305–116. doi:10.1056/NEJMoa2019422.
19. Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson  G, Rowe BH. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review. Acad Emerg Med. 2014;21(7):717–26. doi:10.1111/acem.12407. 
20. Konrad T, Theis C, Mollnau H, Sonnenschein S, Ocete  BQ, Bock K, Münzel T, Rostock T. Primary persistent atrial fibrillation: A distinct arrhythmia subentity of an ablation population. J Cardiovasc Electrophysiol. 2015;26(12):1289–94. doi:10.1111/jce.12818.
21. Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36(46):3250–7. doi:10.1093/eurheartj/ehv513.
22. Kottkamp H, Schreiber D. The Substrate in «Early Persistent» atrial fibrillation: arrhythmia induced, risk factor induced, or from a specific fibrotic atrial cardiomyopathy? JACC Clin Electrophysiol. 2016;2(2):140–2. doi:10.1016/j.jacep.2016.02.010. 
23. Leung DY, Black IW, Cranney GB, Hopkins AP, Walsh WF. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol. 1994;24(3):755–62. doi:10.1016/0735-1097(94)90025-6. 
24. Lim HS, Denis A, Middeldorp ME, Lau DH, Mahajan R, Derval N, Albenque JP, Boveda S, Zellerhoff S, Yamashita  S, Berte B, Mahida S, Komatsu Y, Daly M, Jesel L, Pomier C, Meillet V, Dubois R, Amraoui S, Shah A, Sacher F, Cochet  H, Hocini M, Jaïs P, Sanders P, Haïssaguerre M. Persistent Atrial Fibrillation From the Onset: A Specific subgroup of patients with biatrial substrate involvement and poorer clinical outcome. JACC Clin Electrophysiol. 2016;2(2):129–39. doi:10.1016/j.jacep.2015.12.014. 
25. Limantoro I, de Vos CB, Delhaas T, Weijs B, Blaauw Y, Schotten U, Kietselaer B, Pisters R, Crijns HJ. Clinical correlates of echocardiographic tissue velocity imaging abnormalities of the left atrial wall during atrial fibrillation. Europace. 2014;16(11):1546–53. doi:10.1093/europace/euu047.
26. Mittal S, Ayati S, Stein KM, Schwartzman D, Cavlovich D, Tchou PJ, Markowitz SM, Slotwiner DJ, Scheiner MA, Lerman BB. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation. 2000;101(11):1282–7. doi:10.1161/01.cir.101.11.1282.
27. Miyazaki S, Ito T, Suwa M, Nakamura T, Kobashi A, Kitaura Y. Role of transesophageal echocardiography in the prediction of thromboembolism in patients with chronic nonvalvular atrial fibrillation. Jpn Circ J. 2001;65(10):874–8. doi: 10.1253/jcj.65.874.
28. Ronsoni RM, Saffi MAL, Gonçalves MVM, Nakayama IH, Luz Leiria TL. A new vision at the interface of atrial fibrillation and stroke. Front Cardiovasc Med. 2021;8:689313. doi:10.3389/fcvm.2021.689313.
29. Schmidt AS, Lauridsen KG, Torp P, Bach LF, Rickers H, Løfgren  B. Maximum-fixed energy shocks for cardioverting atrial fibrillation. Eur Heart J. 2020;41(5):626–31. doi:10.1093/eurheartj/ehz585.
30. Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeus­ler  KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Vanassche T, Potpara T, Camm AJ, Heidbüchel  H; External reviewers. 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23(10):1612–76. doi:10.1093/europace/euab065.
31. Stevens PE, Levin A. Kidney Disease: Improving Global Outcomes (KDIGO) СKD Work Group. KDIGO 2012. Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney International. 2013;3(suppl.):1–150. doi:10.7326/0003-4819-158-11-201306040-00007.
32. Thomas L, Abhayaratna WP. Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance. JACC Cardiovasc Imaging. 2017;10(1):65–77. doi:10.1016/j.jcmg.2016.11.003. 
33. Um KJ, McIntyre WF, Healey JS, Mendoza PA, Koziarz  A, Amit G, Chu VA, Whitlock RP, Belley-Côté EP. Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis. Europace. 2019;21(6):856–63. doi:10.1093/europace/euy310.
34. Wałek P, Sielski J, Gorczyca I, Roskal-Wałek J, Starzyk K, Jaskulska-Niedziela E, Bartkowiak R, Wożakowska-Kapłon  B. Left atrial mechanical remodelling assessed as the velocity of left atrium appendage wall motion during atrial fibrillation is associated with maintenance of sinus rhythm after electrical cardioversion in patients with persistent atrial fibrillation. PLoS One. 2020;15(1):e0228239. doi:10.1371/journal.pone.0228239.
35. Willems S, Borof K, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Gessler N, Goette A, Haegeli LM, Heidbuchel H, Kautzner J, Ng GA, Schnabel RB, Suling  A, Szumowski L, Themistoclakis S, Vardas P, van Gelder IC, Wegscheider K, Kirchhof P. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. Eur Heart J. 2022;43(12):1219–30. doi:10.1093/eurheartj/ehab593.